The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Kenneth A. Jacobson

Molecular Recognition Section

Laboratory of Bioorganic Chemistry

National Institutes of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

USA

[email]@helix.nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA. 1998 - 2012
  • Bethesda, USA. 2009
  • Molecular Recognition Section, LBC, NIDDK, National Institutes of Health, USA. 1997 - 2001
  • Molecular Recognition Section, Bldg. 8A, Rm. B1A-19, Laboratory of Bioorganic Chemistry, USA. 2000

References

  1. New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors. Jacobson, K.A., Costanzi, S. Mol. Pharmacol. (2012) [Pubmed]
  2. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions. Jacobson, K.A., Balasubramanian, R., Deflorian, F., Gao, Z.G. Purinergic Signal. (2012) [Pubmed]
  3. Pharmacochemistry of the platelet purinergic receptors. Jacobson, K.A., Deflorian, F., Mishra, S., Costanzi, S. Purinergic Signal. (2011) [Pubmed]
  4. Nucleoside conjugates of quantum dots for characterization of G protein-coupled receptors: strategies for immobilizing A2A adenosine receptor agonists. Das, A., Sanjayan, G.J., Kecskés, M., Yoo, L., Gao, Z.G., Jacobson, K.A. J. Nanobiotechnology (2010) [Pubmed]
  5. P2Y nucleotide receptors: promise of therapeutic applications. Jacobson, K.A., Boeynaems, J.M. Drug Discov. Today (2010) [Pubmed]
  6. GPCR ligand-dendrimer (GLiDe) conjugates: future smart drugs? Jacobson, K.A. Trends Pharmacol. Sci. (2010) [Pubmed]
  7. Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering. Jacobson, K.A., Klutz, A.M., Tosh, D.K., Ivanov, A.A., Preti, D., Baraldi, P.G. Handb. Exp. Pharmacol (2009) [Pubmed]
  8. Introduction to adenosine receptors as therapeutic targets. Jacobson, K.A. Handb. Exp. Pharmacol (2009) [Pubmed]
  9. Development of selective agonists and antagonists of P2Y receptors. Jacobson, K.A., Ivanov, A.A., de Castro, S., Harden, T.K., Ko, H. Purinergic Signal. (2009) [Pubmed]
  10. Preface: special issue on medicinal chemistry of purines. Jacobson, K.A., Zablocki, J., Bhagwat, S. Purinergic Signal. (2009) [Pubmed]
  11. Enhanced A3 adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates. Klutz, A.M., Gao, Z.G., Lloyd, J., Shainberg, A., Jacobson, K.A. J. Nanobiotechnology (2008) [Pubmed]
  12. Neoceptors: reengineering GPCRs to recognize tailored ligands. Jacobson, K.A., Gao, Z.G., Liang, B.T. Trends Pharmacol. Sci. (2007) [Pubmed]
  13. Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5'-triphosphate analogues at the human P2Y2 and P2Y4 receptors. Jacobson, K.A., Costanzi, S., Ivanov, A.A., Tchilibon, S., Besada, P., Gao, Z.G., Maddileti, S., Harden, T.K. Biochem. Pharmacol. (2006) [Pubmed]
  14. Adenosine receptors as therapeutic targets. Jacobson, K.A., Gao, Z.G. Nat. Rev. Drug. Discov (2006) [Pubmed]
  15. Action of nucleosides and nucleotides at 7 transmembrane-spanning receptors. Jacobson, K.A., Costanzi, S., Kim, S.K., Roh, E., Joshi, B.V., Tchilibon, S., Duong, H.T., Gao, Z.G. Nucleosides. Nucleotides. Nucleic. Acids (2006) [Pubmed]
  16. A neoceptor approach to unraveling microscopic interactions between the human A2A adenosine receptor and its agonists. Jacobson, K.A., Ohno, M., Duong, H.T., Kim, S.K., Tchilibon, S., Cesnek, M., Holý, A., Gao, Z.G. Chem. Biol. (2005) [Pubmed]
  17. Molecular recognition at adenine nucleotide (P2) receptors in platelets. Jacobson, K.A., Mamedova, L., Joshi, B.V., Besada, P., Costanzi, S. Semin. Thromb. Hemost. (2005) [Pubmed]
  18. Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection. Jacobson, K.A., Gao, Z.G., Tchilibon, S., Duong, H.T., Joshi, B.V., Sonin, D., Liang, B.T. J. Med. Chem. (2005) [Pubmed]
  19. Molecular recognition at purine and pyrimidine nucleotide (P2) receptors. Jacobson, K.A., Costanzi, S., Ohno, M., Joshi, B.V., Besada, P., Xu, B., Tchilibon, S. Curr. Top. Med. Chem (2004) [Pubmed]
  20. Interactions of flavones and other phytochemicals with adenosine receptors. Jacobson, K.A., Moro, S., Manthey, J.A., West, P.L., Ji, X.D. Adv. Exp. Med. Biol. (2002) [Pubmed]
  21. Structurally related nucleotides as selective agonists and antagonists at P2Y1 receptors. Jacobson, K.A., Moro, S., Hoffmann, C., Kim, Y.C., Kim, H.S., Ravi, R.G., Harden, T.K., Boyer, J.L. Farmaco (2001) [Pubmed]
  22. Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. Jacobson, K.A., Gao, Z.G., Chen, A., Barak, D., Kim, S.A., Lee, K., Link, A., Rompaey, P.V., van Calenbergh, S., Liang, B.T. J. Med. Chem. (2001) [Pubmed]
  23. Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists. Jacobson, K.A., Ji, X., Li, A.H., Melman, N., Siddiqui, M.A., Shin, K.J., Marquez, V.E., Ravi, R.G. J. Med. Chem. (2000) [Pubmed]
  24. In search of selective P2 receptor ligands: interaction of dihydropyridine derivatives at recombinant rat P2X(2) receptors. Jacobson, K.A., Kim, Y.C., King, B.F. J. Auton. Nerv. Syst. (2000) [Pubmed]
  25. A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists. Jacobson, K.A., Xie, R., Young, L., Chang, L., Liang, B.T. J. Biol. Chem. (2000) [Pubmed]
  26. Molecular recognition in P2 receptors: ligand development aided by molecular modeling and mutagenesis. Jacobson, K.A., Hoffmann, C., Kim, Y.C., Camaioni, E., Nandanan, E., Jang, S.Y., Guo, D.P., Ji, X.D., von Kügelgen, I., Moro, S., Ziganshin, A.U., Rychkov, A., King, B.F., Brown, S.G., Wildman, S.S., Burnstock, G., Boyer, J.L., Mohanram, A., Harden, T.K. Prog. Brain Res. (1999) [Pubmed]
  27. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors. Jacobson, K.A., Kim, Y.C., Wildman, S.S., Mohanram, A., Harden, T.K., Boyer, J.L., King, B.F., Burnstock, G. J. Med. Chem. (1998) [Pubmed]
  28. Pharmacological characterization of novel A3 adenosine receptor-selective antagonists. Jacobson, K.A., Park, K.S., Jiang, J.L., Kim, Y.C., Olah, M.E., Stiles, G.L., Ji, X.D. Neuropharmacology (1997) [Pubmed]
 
WikiGenes - Universities